RecruitingPhase 4NCT07434635
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
Sponsor
University of California, San Francisco
Enrollment
62 participants
Start Date
Feb 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Atropine 1% for people with eye disorders. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAtropine 1%
Subtraction of atropine eyedrops from post-operative treatment regimen
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07434635